These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4965683)

  • 1. A modified two-stage assay method for tissue-thromboplastin (TPLN).
    Kale NR
    Thromb Diath Haemorrh; 1966 May; 15(3):403-12. PubMed ID: 4965683
    [No Abstract]   [Full Text] [Related]  

  • 2. A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid, and calcium ions.
    Esmon CT; Owen WG; Jackson CM
    J Biol Chem; 1974 Dec; 249(24):8045-7. PubMed ID: 4430683
    [No Abstract]   [Full Text] [Related]  

  • 3. The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V.
    Esmon CT; Jackson CM
    J Biol Chem; 1974 Dec; 249(24):7791-7. PubMed ID: 4473451
    [No Abstract]   [Full Text] [Related]  

  • 4. The activation of factor X and factor X beta with factor VII or protein M.
    Seegers WH; Ghosh A
    Thromb Res; 1980 Feb 1-15; 17(3-4):501-6. PubMed ID: 6989015
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of human prothrombin by highly purified human factors V and X-a in presence of human antithrombin.
    Rosenberg JS; Beeler DL; Rosenberg RD
    J Biol Chem; 1975 Mar; 250(5):1607-17. PubMed ID: 1112820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the analogy of the action of thrombotropin and autoprothrombin C in some reactions of thrombinogenesis].
    Baskova IP; Strukova SM
    Biokhimiia; 1968; 33(1):137-41. PubMed ID: 5667963
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of activated factor X-induced platelet aggregation: the role of heparin and the plasma inhibitor to activated factor X.
    Yin ET; Giudice LC; Wessler S
    J Lab Clin Med; 1973 Sep; 82(3):390-8. PubMed ID: 4728289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methodological aspects for the determination of the coagulative activity of coagulation factors II, V, VII and X from dog plasma].
    Mischke R
    Zentralbl Veterinarmed A; 1994 Aug; 41(6):431-42. PubMed ID: 7863734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polylysine on the activation of prothrombin. Polylysine substitutes for calcium ions and factor V in the factor Xa catalyzed activation of prothrombin.
    Vogel CN; Butkowski RJ; Mann KG; Lundblad RL
    Biochemistry; 1976 Jul; 15(15):3265-9. PubMed ID: 986155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiments on the nature of the prothrombin-converting principle: alteration of proaccelerin by thrombin.
    Prentice CR; Ratnoff OD; Breckenridge RT
    Br J Haematol; 1967 Nov; 13(6):898-914. PubMed ID: 6075445
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermediates of prothrombin activation.
    Mann KG; Bajaj SP; Heldebrant CM; Butkowski RJ; Fass DN
    Ser Haematol; 1973; 6(4):479-93. PubMed ID: 4794965
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G
    Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophages synthesize factor X and secrete factor X/Xa-containing prothrombinase activity into the surrounding medium.
    Pejler G; Lunderius C; Tomasini-Johansson B
    Thromb Haemost; 2000 Sep; 84(3):429-35. PubMed ID: 11019967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International normalised ratio and liver impairment.
    Kovacs M
    Lancet; 2002 May; 359(9318):1695. PubMed ID: 12020554
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effect of factor Xa or tissue thromboplastin and factor VII on the activation of plasminogen.
    Wiman B; Holm T; Prydz H
    Thromb Res; 1976 Nov; 9(5):523-5. PubMed ID: 136768
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies regarding the effect of foreign-surface contact on the one-stage prothrombin time determination.
    Shanberge JN; Matsuoka T
    Thromb Diath Haemorrh; 1966 May; 15(3):442-50. PubMed ID: 5989030
    [No Abstract]   [Full Text] [Related]  

  • 18. Physicochemical and biological properties of canine prothrombin and thrombin.
    Takeuchi T; Takeda Y
    Thromb Res; 1978 Apr; 12(4):635-44. PubMed ID: 663900
    [No Abstract]   [Full Text] [Related]  

  • 19. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between factor V and activated factor X in the generation of prothrombinase.
    Barton PG; Jackson CM; Hanahan DJ
    Nature; 1967 May; 214(5091):923-4. PubMed ID: 6054988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.